|LIVONGO HEALTH, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger|
|By GLOBE NEWSWIRE|
|Wednesday, 05 August 2020 06:57|
WILMINGTON, Del., Aug. 05, 2020 (GLOBE NEWSWIRE)
WILMINGTON, Del., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Livongo Health, Inc. (“Livongo”) (NASDAQ GS: LVGO) regarding possible breaches of fiduciary duties and other violations of law related to Livongo’s agreement to merge with Teladoc Health, Inc. (“Teladoc”) (NYSE: TDOC). Under the terms of the agreement, shareholders of Livongo will receive 0.592 of a share of Teladoc and a cash consideration of $11.33 for each share of Livongo they own.
To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-livongo-health-inc.
If you would like to discuss this investigation and your rights cost and obligation free, please contact Seth D. Rigrodsky or Gina M. Serra toll free at (888) 969-4242 or by e-mail at [email protected].
Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.